Pathogens rapidly evolve resistance to antibiotics. AI could keep us a step ahead of deadly infections.
There are more effective ways to give the tuberculosis vaccine.
Hugh Ramsay's Two girls in white, was painted just two years before he died at the age of 28 in 1906. It is the central work in the National Gallery of Australia's survey exhibition.
Many of the most fundamental aspects of TB disease remain unknown. For example, after exposure to the organism that causes TB, why do only some people get infected and only some of those fall ill?
There's a big market for new treatments for TB, malaria and other ailments. But most of these diseases afflict low-income people unable to pay for medicine.
Treating infectious diseases is a huge challenge because patients often fail to take the medicine for the long duration, especially for tuberculosis. Now there's a new device that may help.
The push to end TB requires significant investment into the research and development of new diagnostics and treatments.
Tuberculosis kills more people globally than any other infectious disease. A human-rights approach and investment in quality care are essential to ending the global epidemic.
New research shows that the treatment of drug resistant-TB can be reduced from the current duration of 20 to 24 months to less than a year.
In Southern Africa, high rates of HIV infection have been the primary driver of TB
Warthogs are an important species in managing bovine TB.
In Manitoba, Canada, researchers have used health databases to better understand how people with tuberculosis interact with the health-care system.
Using a large number of computers to screen TB drugs reduces the cost and time.
Despite the myth of consumption as an ethereal, wasting disease, the more prosaic truth is that the Brontës likely infected one another with tuberculosis.
We cannot end TB with century-old technologies and poor quality care. It is time to reinvent the way we are managing TB, and overcome our collective failures of the imagination.
Antibiotic resistance is a major and growing global health threat. These five recent examples show us how dangerous it can be.
The reason that nanoparticles hold such hope for TB treatment is that they can be carefully targeted.
Treatment for drug-resistant TB remains problematic as the painful daily injectable patients receive for at least six months leaves more than 60% deaf.
Class action is a newish feature within South Africa's legal landscape. Cases such as the silicosis matter are likely to influence many more.
The TB epidemic is out of control in Canada's North. Eliminating the disease will require accurate data as well as government investment.